Research - Bethesda, Maryland, United States
RemeGenix is a biopharmaceutical company focused on the development and commercialization of disease-altering therapies to prevent and treat Alzheimer's disease (AD). AD is a multi-factorial disease with no approved disease-altering drugs, and a well-established link to Amyloid Precursor Protein. Numerous therapeutics in development, aimed at treating Alzheimer's disease, are focused on specific points along the amyloid cascade, whereas Cortica's technology was specifically designed as a specific modulator of the amyloid cascade and is therapeutically focused on improvement in cognition vs an artefactual pathology.
Gmail
Apache
Blue Host
Google Maps
Bootstrap Framework